Home › Clear-cell metastatic renal cell carcinoma › Michigan › Ann Arbor
Clear-cell metastatic renal cell carcinoma clinical trials in Ann Arbor, MI
3 studies for Clear-cell metastatic renal cell carcinoma are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
RecruitingPhase 1/2
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
RecruitingPhase 3
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi away
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi away
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi away
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RecruitingPhase 3
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi away
Clear-cell metastatic renal cell carcinoma trials in other cities
- Baldwin Park, CA7 studies
- New York City, NY5 studies
- Dallas, TX5 studies
- Nashville, TN5 studies
- Rochester, MN4 studies
- Waukegan, IL4 studies
- Cleveland, OH4 studies
- St. Louis, MO4 studies
- San Francisco, CA3 studies
- Houston, TX3 studies
- Omaha, NE3 studies
- San Diego, CA3 studies
Other studies in Ann Arbor
- Breast Cancer27 studies
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Cancer (all types)25 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Stroke12 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.